RNAi modulation of scap and therapeutic uses thereof

Details for Australian Patent Application No. 2007297388 (hide)

Owner Board of Regents, The University of Texas System Alnylam Pharmaceuticals, Inc.

Inventors Soutschek, Juergen; Goldstein, Joseph L.; Tan, Pamela; Horton, Jay D.; Moon, Young-Ah; Brown, Michael S.

Agent Pizzeys

Pub. Number AU-A-2007297388

PCT Pub. Number WO2008/036638

Priority 60/845,289 18.09.06 US

Filing date 18 September 2007

Wipo publication date 27 March 2008

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/036638 Priority application(s): WO2008/036638

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007297395-Gravel pack apparatus that includes a swellable element

2007297384-Flexible tamping device